# Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

> **NCT00637793** · PHASE2 · COMPLETED · sponsor: **TorreyPines Therapeutics** · enrollment: 24 (estimated)

## Conditions studied

- Xerostomia
- Sjogren's Syndrome

## Interventions

- **DRUG:** NGX267
- **DRUG:** NGX267
- **DRUG:** NGX267
- **DRUG:** NGX267

## Key facts

- **NCT ID:** NCT00637793
- **Lead sponsor:** TorreyPines Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637793, "Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00637793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*